
AZD-9574
AZD-9574
Catalog No. M28886
AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.
Size | Price / USD | Stock | Quantity |
5MG | 295 | In Stock |
![]() ![]() |
10MG | 475 | In Stock |
![]() ![]() |
25MG | 773 | In Stock |
![]() ![]() |
50MG | 1071 | In Stock |
![]() ![]() |
100MG | 1422 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAZD-9574
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1.Hu K, Yao X. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro. Phytother Res. 2003 Jun;17(6):620-6.
molnova catalog



related products
-
BGP-15
A PARP inhibitor and an inducer of HSF-1/HSP72 (cotreatment with heat) in vtiro.
-
Gemcabene
Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.
-
Talazoparib
Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM.